Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inc PfizerfiledCriticalInc Pfizer
Priority to HN2001000113ApriorityCriticalpatent/HN2001000113A/en
Publication of HN2001000113ApublicationCriticalpatent/HN2001000113A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Preparation Of Compounds By Using Micro-Organisms
(AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A NUEVOS DERIVADOS DE HIGROMICINA A QUE SON UTILES COMO AGENTES ANTIBACTERIANOS Y ANTIPROTOZOARIOS EN MAMIFEROS, INCLUYENDO EL SER HUMANO, ASI COMO EN PECES Y AVES.THE PRESENT INVENTION REFERS TO NEW HYGROMYCIN DERIVATIVES THAT ARE USEFUL AS ANTIBACTERIAL AND ANTIPROTOZOAR AGENTS IN MAMMALS, INCLUDING THE HUMAN BEING, AS WELL AS FISH AND BIRDS.
HN2001000113A2001-05-252001-05-25
HYGROMYCIN DERIVATIVES A
HN2001000113A
(en)